Press

EMPOWER CLINICS ANNOUNCES RECEIPT OF CONTRACTS AND BUDGET FOR FIRST CLINICAL TRIAL

EMPOWER CLINICS ANNOUNCES RECEIPT OF CONTRACTS AND BUDGET FOR FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY AND PROVIDES CORPORATE UPDATE VANCOUVER, B.C.: OCTOBER 23, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") a healthcare company with a developing research and clinical trials division announces its subsidiary EPW Curesearch LLC (“EPWC”) has been awarded its first clinical trial and has received contracts and budget from the trial...

read more

EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY AND PROVIDES CORPORATE UPDATE

EMPOWER CLINICS ANNOUNCES AWARD OF FIRST CLINICAL TRIAL FROM GLOBAL FORTUNE 500 PHARMACEUTICAL COMPANY AND PROVIDES CORPORATE UPDATE VANCOUVER, B.C.: SEPTEMBER 25, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") a healthcare company with a developing research and clinical trials division announces its subsidiary EPW Curesearch LLC (“EPWC”) has been awarded its first clinical trial from a major European pharmaceutical company with a market cap over $100 Billion,...

read more

Empower Clinics Provides Corporate Update

Empower Clinics Provides Corporate Update VANCOUVER, B.C.: AUGUST 18, 2023 – EMPOWER CLINICS INC (CSE:EPW) (PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company with a developing research and clinical trials division announces various corporate updates. CEASE TRADE ORDER On August 15th, 2023 the British Columbia Securities Commission (“BCSC”) issued a bulletin announcing Empower is suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as...

read more

Categories